CAJ | 학술논문

目的：探讨布地奈德联合孟鲁司特治疗支气管哮喘的疗效和安全性。方法：90例患者随机分为治疗组和对照组，各45例。对照组给予吸氧、抗炎、平喘、化痰等常规治疗，治疗组在常规治疗的基础上加用布地奈德和孟鲁司特，分别比较两者患者的疗效和肺功能等指标。结果：治疗组的有效率高达93.33%，高于对照组的68.89%，差异有统计学意义（ P＜0.05）；治疗组的肺功能改善程度和症状缓解时间均优于对照组，两组比较差异有统计学意义（ P＜0.05）。结论：布地奈德联合孟鲁司特治疗支气管哮喘具有显著的治疗效果和良好的安全性。
목적：탐토포지내덕연합맹로사특치료지기관효천적료효화안전성。방법：90례환자수궤분위치료조화대조조，각45례。대조조급여흡양、항염、평천、화담등상규치료，치료조재상규치료적기출상가용포지내덕화맹로사특，분별비교량자환자적료효화폐공능등지표。결과：치료조적유효솔고체93.33%，고우대조조적68.89%，차이유통계학의의（ P＜0.05）；치료조적폐공능개선정도화증상완해시간균우우대조조，량조비교차이유통계학의의（ P＜0.05）。결론：포지내덕연합맹로사특치료지기관효천구유현저적치료효과화량호적안전성。
objective To investigate the clinical efficacy and safety of budesonide and montelukast in treating patients with bronchial asthma. Method 90 patients were divided into the therapy group and the control group by half. The patients in the control group were given oxygen inhalation,anti-inflammation,relieving asthma,eliminating phlegm and other conventional treatment. the patients in the therapy group were added the usage of budesonide and montelukast on the basis of conventional treatment. The therapeutic effect and pulmonary function were compared between the two groups. Results The effective rate of the treatment group was 93. 33%,which was higher than 68. 89% in the control group,the difference had statistical significance (P<0. 05). The improvement of pulmonary function and the degree of symptom remis-sion time of the treatment group were better than the control group,there was significant difference between the two groups(P<0. 05). Con-clusion The treatment combined with budesonide and montelukast could significantly improve the clinical efficacy,and has a good safety.